Back to search

Netherlands· NL-b0dabe409114

Megalotect 100 E/ml oplossing voor infusie

A cytomegalovirus immunoglobulin product containing humaan cytomegalovirus immunoglobuline, registered in Netherlands by Biotest Pharma GmbH. The same ATC class is registered in 9 of our 19 countries.

ATC J06BB09

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedMegalotect 100 E/ml oplossing voor in…ATCJ06BB09REGISTER NO.NL-b0dabe409114PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Cytomegalovirus immunoglobulin is registered in 9 of 19 countries.

Countries holding a registration under ATC J06BB09 (cytomegalovirus immunoglobulin), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Cytomegalovirus immunoglobulin · ATC J06BB09

9 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Finlandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
HUMAAN CYTOMEGALOVIRUS IMMUNOGLOBULINE
Manufacturer
Biotest Pharma GmbH
Country
Netherlands (NL)
ATC code
J06BB09
ATC class
Cytomegalovirus immunoglobulin
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    123161

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cytomegalovirus immunoglobulin in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cytomegalovirus immunoglobulin products

Authorised across Europe · EMA

The same active substance is authorised in 17 EEA countries. Names it is sold under:

  • Austria · Cytotect Cp
  • Belgium · Megalotect
  • Czechia · Cymvigo
  • Germany · Cytotect Cp
  • Spain · Megalotect
  • United Kingdom (Northern Ireland) · Cytotect Cp
  • Greece · Megalotect Cp
  • Croatia · Cytotect Cp
  • Hungary · Cytotect Cp
  • Ireland · Megalotect
  • Italy · Cytomegatect
  • Lithuania · Cymvigo
  • Poland · Megalotect Cp
  • Portugal · Megalotect Cp
  • Romania · Cytotect Cp
  • Slovenia · Megalotect
  • Slovakia · Cytotect

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8432ebc1-ae4c-46a4-b229-78ea53c6b616
GET /v1/drugs/8432ebc1-ae4c-46a4-b229-78ea53c6b616?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123161_smpc.pdf",
  "strength": null,
  "atc_label": "Cytomegalovirus Immunoglobulin",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123161",
  "excipients": [
    "GLYCINE (E 640)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "HUMAAN CYTOMEGALOVIRUS IMMUNOGLOBULINE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123161.pdf",
  "authorised_at": "2018/10/18",
  "procedure_number": "DE/H/4905/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "123161",
  "additional_monitoring": "N"
}

See everything about cytomegalovirus immunoglobulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.